During the past decade, Midwest Prostate Urology Health Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Midwest Prostate Urology Health Center" are "Prostate Cancer" (3 trials), "Benign Prostatic Hyperplasia" (1 trials) and "Metastatic Androgen Independent Prostate Cancer" (1 trials). Many other conditions were trialed in "Midwest Prostate Urology Health Center" in a lesser frequency.

Most popular intervention types in "Midwest Prostate Urology Health Center" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "APC-Placebo" (1 trials), "APC8015F" (1 trials), "Lonidamine" (1 trials), "Plenaxis" (1 trials) and "Sipuleucel-T" (1 trials). Other intervention names were less common.

The vast majority of trials in "Midwest Prostate Urology Health Center" are 5 trials for "Male" genders.

Currently, there are NaN active trials in "Midwest Prostate Urology Health Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Midwest Prostate Urology Health Center, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Midwest Prostate Urology Health Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".